Strides Pharma Science Ltd. has been honored in the S&P Global Sustainability Yearbook 2025, placing it among the top 10 percent of companies globally.

The recognition highlights the company’s Environmental, Social, and Governance (ESG) performance and commitment to sustainability.

The S&P Global Sustainability Yearbook assesses companies across various industries based on ESG performance. For the 2025 edition, 7,690 companies across more than 60 industries were evaluated, with 780 making it into the Yearbook. Within the pharmaceutical and biotechnology sector, 35 companies were included globally, with 16 in the top 10 percent. In India, 51 companies were recognized, including five pharmaceutical and biotechnology firms achieving top 5 or 10 percent placement.

Strides demonstrated strong performance across ESG dimensions. In Environmental Stewardship, the company ranked in the 87th percentile, with waste management practices placing it in the 99th percentile for Waste and Pollutants. It also achieved a 94th percentile ranking in Energy Management and Environmental Policy and Management.

In Social Responsibility, Strides ranked in the 97th percentile, with a 100th percentile ranking in Customer Relations and high rankings in Human Capital Management (96th percentile) and Contribution to Societal Healthcare (95th percentile). The company also ranked in the 94th percentile for Business Ethics, supported by strong performance in Policy Influence and Crisis Management.

This recognition reflects Strides progress in integrating ESG principles across its operations. The company continues to focus on improving sustainability initiatives and aligning its business practices with long-term growth objectives.